Skip to main content
Fig. 6 | Diagnostic Pathology

Fig. 6

From: Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant

Fig. 6

The relative expression levels of FGF23 in PMTs, as determined by real-time RT-PCR analysis. The expression level of FGF23 was higher in PMTs with TIO (case Nos. 1 and 2) than in PMTs without TIO (case Nos. 6 and 7) or chondromyxoid fibroma (case No. 9). The FGF23 gene transcript was not identified in the other tumors examined, including myxoid liposarcoma (case No. 23). Expression levels were normalized to GAPDH as an internal control

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us